TY - JOUR
T1 - Application of negative design to design a more desirable virtual screening library
AU - Yang, Zi Yi
AU - He, Jun Hong
AU - Lu, Ai Ping
AU - Hou, Ting Jun
AU - Cao, Dong Sheng
N1 - Funding Information:
This work is financially supported by the National Key Basic Research Program (Grant 2015CB910700), the National Science Foundation of China (Grants 21575128 and 81773632), the Zhejiang Provincial Natural Science Foundation of China (Grant LZ19H300001), and the Project of Innovation-Driven Plan in Central South University. The studies meet with the approval of the university’s review board.
Publisher copyright:
© 2020 American Chemical Society
PY - 2020/5/14
Y1 - 2020/5/14
N2 - Negative design is a group of virtual screening methods that aims at weeding out compounds with undesired properties during the early stages of drug development. These methods are mainly designed to predict three important types of pharmacological properties: drug-likeness, frequent hitters, and toxicity. In order to achieve high screening efficiency, most negative design methods are physicochemical property-based and/or substructure-based rules or filters. Such methods have advantages of simplicity and good interpretability, but they also suffer from some defects such as inflexibility, discontinuity, and hard decision-making. In this review, the advances in negative design for the evaluations of drug-likeness, frequent hitters, and toxicity are outlined. In addition, the related Web servers and software packages developed recently for negative design are summarized. Finally, future research directions in this field are discussed.
AB - Negative design is a group of virtual screening methods that aims at weeding out compounds with undesired properties during the early stages of drug development. These methods are mainly designed to predict three important types of pharmacological properties: drug-likeness, frequent hitters, and toxicity. In order to achieve high screening efficiency, most negative design methods are physicochemical property-based and/or substructure-based rules or filters. Such methods have advantages of simplicity and good interpretability, but they also suffer from some defects such as inflexibility, discontinuity, and hard decision-making. In this review, the advances in negative design for the evaluations of drug-likeness, frequent hitters, and toxicity are outlined. In addition, the related Web servers and software packages developed recently for negative design are summarized. Finally, future research directions in this field are discussed.
UR - http://www.scopus.com/inward/record.url?scp=85084695342&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.9b01476
DO - 10.1021/acs.jmedchem.9b01476
M3 - Review article
C2 - 31928004
AN - SCOPUS:85084695342
SN - 0022-2623
VL - 63
SP - 4411
EP - 4429
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 9
ER -